Samsara Biocapital Gp, Llc - Net Worth and Insider Trading

Samsara Biocapital Gp, Llc Net Worth

The estimated net worth of Samsara Biocapital Gp, Llc is at least $469 Million dollars as of 2024-12-29. Samsara Biocapital Gp, Llc is the 10% Owner of Scholar Rock Holding Corp and owns about 6,788,609 shares of Scholar Rock Holding Corp (SRRK) stock worth over $302 Million. Samsara Biocapital Gp, Llc is the 10% Owner of Mineralys Therapeutics Inc and owns about 5,074,916 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $65 Million. Samsara Biocapital Gp, Llc is also the 10% Owner of Cargo Therapeutics Inc and owns about 4,415,689 shares of Cargo Therapeutics Inc (CRGX) stock worth over $62 Million. Besides these, Samsara Biocapital Gp, Llc also holds Neurogene Inc (NGNE) . Details can be seen in Samsara Biocapital Gp, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samsara Biocapital Gp, Llc has not made any transactions after 2024-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Samsara Biocapital Gp, Llc

To

Samsara Biocapital Gp, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samsara Biocapital Gp, Llc owns 1 companies in total, including Scholar Rock Holding Corp (SRRK) .

Click here to see the complete history of Samsara Biocapital Gp, Llc’s form 4 insider trades.

Insider Ownership Summary of Samsara Biocapital Gp, Llc

Ticker Comapny Transaction Date Type of Owner
SRRK Scholar Rock Holding Corp 2023-10-16 10 percent owner

Samsara Biocapital Gp, Llc Latest Holdings Summary

Samsara Biocapital Gp, Llc currently owns a total of 4 stocks. Among these stocks, Samsara Biocapital Gp, Llc owns 6,788,609 shares of Scholar Rock Holding Corp (SRRK) as of October 16, 2023, with a value of $302 Million and a weighting of 64.39%. Samsara Biocapital Gp, Llc owns 5,074,916 shares of Mineralys Therapeutics Inc (MLYS) as of February 12, 2024, with a value of $65 Million and a weighting of 13.88%. Samsara Biocapital Gp, Llc also owns 4,415,689 shares of Cargo Therapeutics Inc (CRGX) as of May 30, 2024, with a value of $62 Million and a weighting of 13.32%. The other 1 stocks Neurogene Inc (NGNE) have a combined weighting of 8.41% among all his current holdings.

Latest Holdings of Samsara Biocapital Gp, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRRK Scholar Rock Holding Corp 2023-10-16 6,788,609 44.46 301,821,556
MLYS Mineralys Therapeutics Inc 2024-02-12 5,074,916 12.82 65,060,423
CRGX Cargo Therapeutics Inc 2024-05-30 4,415,689 14.14 62,437,842
NGNE Neurogene Inc 2024-11-26 1,717,127 22.97 39,442,407

Holding Weightings of Samsara Biocapital Gp, Llc


Samsara Biocapital Gp, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 1 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Scholar Rock Holding Corp is the acquisition of 2,189,781 shares on October 16, 2023, which cost Samsara Biocapital Gp, Llc around $15 Million.

According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 1 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mineralys Therapeutics Inc is the acquisition of 555,555 shares on February 12, 2024, which cost Samsara Biocapital Gp, Llc around $7 Million.

According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 2 transactions in Cargo Therapeutics Inc (CRGX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Cargo Therapeutics Inc is the acquisition of 294,000 shares on May 30, 2024, which cost Samsara Biocapital Gp, Llc around $5 Million.

More details on Samsara Biocapital Gp, Llc's insider transactions can be found in the Insider Trading History of Samsara Biocapital Gp, Llc table.

Insider Trading History of Samsara Biocapital Gp, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samsara Biocapital Gp, Llc Trading Performance

GuruFocus tracks the stock performance after each of Samsara Biocapital Gp, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samsara Biocapital Gp, Llc is 32.98%. GuruFocus also compares Samsara Biocapital Gp, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samsara Biocapital Gp, Llc within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Samsara Biocapital Gp, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Samsara Biocapital Gp, Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.07 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.06 LIMIT LIMIT LIMIT LIMIT LIMIT

Samsara Biocapital Gp, Llc Ownership Network

Ownership Network List of Samsara Biocapital Gp, Llc

No Data

Ownership Network Relation of Samsara Biocapital Gp, Llc

Insider Network Chart

Samsara Biocapital Gp, Llc Owned Company Details

What does Scholar Rock Holding Corp do?

Who are the key executives at Scholar Rock Holding Corp?

Samsara Biocapital Gp, Llc is the 10 percent owner of Scholar Rock Holding Corp. Other key executives at Scholar Rock Holding Corp include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Jing L. Marantz , and Chief Commercial Officer Tracey Sacco .

Scholar Rock Holding Corp (SRRK) Insider Trades Summary

Over the past 18 months, Samsara Biocapital Gp, Llc made 1 insider transaction in Scholar Rock Holding Corp (SRRK) with a net purchase of 2,189,781. Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 336,643 shares made by Edward H Myles , a net sale of 35,372 shares made by Mo Qatanani , and a net sale of 13,709 shares made by Caryn Parlavecchio .

In summary, during the past 3 months, insiders sold 3,578,573 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 3,578,573 shares. During the past 18 months, 3,729,751 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,579,493 shares were bought by its insiders, resulting in a net purchase of 2,849,742 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Scholar Rock Holding Corp Insider Transactions

No Available Data

Samsara Biocapital Gp, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Samsara Biocapital Gp, Llc. You might contact Samsara Biocapital Gp, Llc via mailing address: 251 Churchill Avenue, Palo Alto Ca 94301.

Discussions on Samsara Biocapital Gp, Llc

No discussions yet.